Universitätsklinikum Heidelberg

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma (2021) Kang EY, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, et al. Journal article TROPHY registry — status report (2021) Thomale UW, Auer C, Spennato P, Schaumann A, Behrens P, Gorelyshev S, Bogoslovskaia E, et al. Journal article 2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde (2021) Musto P, Engelhardt M, Caers J, Bolli N, Kaiser M, Van De Donk N, Terpos E, et al. Journal article, Review article Direct and indirect costs and cost drivers of Tuberous sclerosis complex in children, adolescents, and caregivers: A multicenter cohort study (2021) Zoellner JP, Grau J, Schubert-Bast S, Kurlemann G, Hertzberg C, Wiemer-Kruel A, Bast T, et al. Journal article Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung (2021) Agaimy A, Stöhr R, Michal M, Christopoulos P, Winter H, Zhang L, Stenzinger A, et al. Journal article Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: A multicentre cohort study from Germany (2021) Willems LM, Schubert-Bast S, Grau J, Hertzberg C, Kurlemann G, Wiemer-Kruel A, Bast T, et al. Journal article Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article Single- And double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM (2021) Truger MS, Duell J, Zhou X, Heimeshoff L, Ruckdeschel A, John M, Riedel A, et al. Journal article Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss (2021) Richard EM, Bakhtiari S, Marsh AP, Kaiyrzhanov R, Wagner M, Shetty S, Pagnozzi A, et al. Journal article Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Journal article